1. Home
  2. HUDI vs QNRX Comparison

HUDI vs QNRX Comparison

Compare HUDI & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

N/A

Current Price

$1.17

Market Cap

17.2M

Sector

Industrials

ML Signal

N/A

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$6.25

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
QNRX
Founded
1998
2018
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
14.5M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
HUDI
QNRX
Price
$1.17
$6.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.4K
21.6K
Earning Date
01-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$5.20
52 Week High
$5.46
$41.80

Technical Indicators

Market Signals
Indicator
HUDI
QNRX
Relative Strength Index (RSI) 48.56 47.25
Support Level $1.10 $5.34
Resistance Level $1.30 $6.98
Average True Range (ATR) 0.07 0.46
MACD 0.00 0.13
Stochastic Oscillator 34.48 69.13

Price Performance

Historical Comparison
HUDI
QNRX

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: